Title: HPAPI Drug Manufacturing Trends

Managing accelerated timelines in manufacturing high-potency drugs. Highly potent API (HPAPI) drugs make up a growing percentage of the small molecule drug development pipeline and this group of products is growing faster than the overall small molecule segment,1 largely due to their usefulness in cancer treatments. Many of these drugs have accelerated timelines for approval and commercial development, which can be challenging for drug developers to keep up with. On the front-end, new technologies…

Click Here For Complete Article Text


   Person Information
   Application Sequencing
 325412 - Pharmaceutical Preparation Manufacturing                
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor
  • HighTech / Internet / AI

  • Manufacturing


  • Market

  • Trends




  • Contract Pharma


  • 5/1/2020


  • Article